Home > Cancer and Treatments > Pancreatic Cancer > Research > Publications

Articles by Mark Zalupski, M.D.

click on the authors to view .pdf documents

 

2007

Desai SP, Ben-Josef E, Normolle DP, Francis IR, Greenson JK, Simeone DM, Chang AE, Colletti LM, Lawrence TS, Zalupski MM.
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
J Clin Oncol. 2007 Oct 10;25(29):4587-92.
PMID: 17379445 [Pub Med - indexed for MEDLINE]

Murphy JD, Adusumilli S, Griffith KA, Ray ME, Zalupski MM, Lawrence TS, Ben-Josef E.
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):801-8. Epub 2007 Mar 26.
PMID: 17548814 [Pub Med indexed for MEDLINE]

 

2006

Talamonti MS, Small W Jr, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, Zalupski MM, Hoffman JP, Freedman GM, Kinsella TJ, Philip PA, McGinn CJ.
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
Ann Surg Oncol. 2006 Feb;13(2):150-8. Epub 2006 Jan 19.
PMID: 16418882 [Pub Med indexed for MEDLINE]

 

2005

El-Rayes BF, Zalupski MM, Shields AF, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Adsay V, Philip PA.
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
Invest New Drugs. 2005 Dec;23(6):583-90.
PMID: 16034525 [Pub Med indexed for MEDLINE]

Schneider BJ, Ben-Josef E, McGinn CJ, Chang AE, Colletti LM, Normolle DP, Hejna GF, Lawrence TS, Zalupski MM.
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1325-30. Epub 2005 Jul 1.
PMID: 15993549 [Pub Med indexed for MEDLINE]

 

Return to top

2004

Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ.
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1461-7.
PMID: 15275733 [Pub Med indexed for MEDLINE]

Muler JH, McGinn CJ, Normolle D, Lawrence T, Brown D, Hejna G, Zalupski MM.
Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.
J Clin Oncol. 2004 Jan 15;22(2):238-43. Epub 2003 Dec 9.
PMID: 14665608 [Pub Med indexed for MEDLINE]

 

2003

Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, Lawrence TS, McGinn CJ.
Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
J Gastrointest Surg. 2003 Sep-Oct;7(6):766-72.
PMID: 13129554 [Pub Med indexed for MEDLINE]

El-Rayes BF, Zalupski MM, Shields AF, Vaishampayan U, Heilbrun LK, Jain V, Adsay V, Day J, Philip PA.
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.
J Clin Oncol. 2003 Aug 1;21(15):2920-5.
PMID: 12885810 [Pub Med indexed for MEDLINE]

Return to the top of the page

For a complete list of Mark Zalupski's publications, visit Pub Med and do a search.

Adjust text size

University of Michigan Comprehensive Cancer Center
1500 East Medical Center Drive
Ann Arbor, MI 48109

This site is part of the U-M Health System. The information presented is not a tool for self diagnosis or a substitute for professional care. © 2008 U-M Comprehensive Cancer Center